ClinicalTrials.gov
public full text
Public Domain
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis#967447
- SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease#918411
- Dapagliflozin With or Without Spironolactone for HFpEF#969596
- FLT3 inhibitors in AML: from classic scaffolds to next-generation approaches.#378403
- FCD-11: A First-in-Class COMPASS Inhibitor in Cancer Therapeutics#610857
Record · ID 398242
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive